カテゴリー： QYResearch, 世界, 部品/材料

世界の医療用放射線源市場インサイト及び予測（Tc-99m、コバルト60、ヨウ素放射性同位元素）

◆英語タイトル：Global Medical Radioactive Source Market Insights, Forecast to 2028
	◆商品コード：QY22JLX01557 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：114 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、医療用放射線源のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に医療用放射線源の世界市場のxxx％を占める「Tc-99m」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「核治療」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
医療用放射線源の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの医療用放射線源市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

医療用放射線源のグローバル主要企業には、NRG、Mayak、NTP Radioisotopes、ANSTO、Nordion、IRE、Curium Pharma、Eckert & Ziegler Strahlen、China Isotope & Radiation Corporation (CIRC)、Polatom、Board of Radiation and Isotope Technologyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

医療用放射線源市場は、種類と用途によって区分されます。世界の医療用放射線源市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
Tc-99m、コバルト60、ヨウ素放射性同位元素

【用途別セグメント】
核治療、機器放射線源、診断、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 医療用放射線源製品概要
- 種類別市場（Tc-99m、コバルト60、ヨウ素放射性同位元素）
- 用途別市場（核治療、機器放射線源、診断、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の医療用放射線源販売量予測2017-2028
- 世界の医療用放射線源売上予測2017-2028
- 医療用放射線源の地域別販売量
- 医療用放射線源の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別医療用放射線源販売量
- 主要メーカー別医療用放射線源売上
- 主要メーカー別医療用放射線源価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（Tc-99m、コバルト60、ヨウ素放射性同位元素）
- 医療用放射線源の種類別販売量
- 医療用放射線源の種類別売上
- 医療用放射線源の種類別価格
・用途別市場規模（核治療、機器放射線源、診断、その他）
- 医療用放射線源の用途別販売量
- 医療用放射線源の用途別売上
- 医療用放射線源の用途別価格
・北米市場
- 北米の医療用放射線源市場規模（種類別、用途別）
- 主要国別の医療用放射線源市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの医療用放射線源市場規模（種類別、用途別）
- 主要国別の医療用放射線源市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の医療用放射線源市場規模（種類別、用途別）
- 主要国別の医療用放射線源市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の医療用放射線源市場規模（種類別、用途別）
- 主要国別の医療用放射線源市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの医療用放射線源市場規模（種類別、用途別）
- 主要国別の医療用放射線源市場規模（トルコ、サウジアラビア）
・企業情報
NRG、Mayak、NTP Radioisotopes、ANSTO、Nordion、IRE、Curium Pharma、Eckert & Ziegler Strahlen、China Isotope & Radiation Corporation (CIRC)、Polatom、Board of Radiation and Isotope Technology
・産業チェーン及び販売チャネル分析
- 医療用放射線源の産業チェーン分析
- 医療用放射線源の原材料
- 医療用放射線源の生産プロセス
- 医療用放射線源の販売及びマーケティング
- 医療用放射線源の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 医療用放射線源の産業動向
- 医療用放射線源のマーケットドライバー
- 医療用放射線源の課題
- 医療用放射線源の阻害要因
・主な調査結果

Market Analysis and Insights: Global Medical Radioactive Source Market
Due to the COVID-19 pandemic, the global Medical Radioactive Source market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Tc-99m accounting for % of the Medical Radioactive Source global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Nuclear Therapy segment is altered to an % CAGR throughout this forecast period.
China Medical Radioactive Source market size is valued at US$ million in 2021, while the US and Europe Medical Radioactive Source are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Medical Radioactive Source landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Medical Radioactive Source include NRG, Mayak, NTP Radioisotopes, ANSTO, Nordion, IRE, Curium Pharma, Eckert & Ziegler Strahlen and China Isotope & Radiation Corporation (CIRC), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Medical Radioactive Source capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Medical Radioactive Source by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Medical Radioactive Source Scope and Segment
Medical Radioactive Source market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Medical Radioactive Source market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Tc-99m
Cobalt-60
Iodine Radioisotopes
Segment by Application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Others
By Company
NRG
Mayak
NTP Radioisotopes
ANSTO
Nordion
IRE
Curium Pharma
Eckert & Ziegler Strahlen
China Isotope & Radiation Corporation (CIRC)
Polatom
Board of Radiation and Isotope Technology
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Medical Radioactive Source Product Introduction
1.2 Market by Type
1.2.1 Global Medical Radioactive Source Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Tc-99m
1.2.3 Cobalt-60
1.2.4 Iodine Radioisotopes
1.3 Market by Application
1.3.1 Global Medical Radioactive Source Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Nuclear Therapy
1.3.3 Equipment Radioactive Source
1.3.4 Diagnosis
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Medical Radioactive Source Production
2.1 Global Medical Radioactive Source Production Capacity (2017-2028)
2.2 Global Medical Radioactive Source Production by Region: 2017 VS 2021 VS 2028
2.3 Global Medical Radioactive Source Production by Region
2.3.1 Global Medical Radioactive Source Historic Production by Region (2017-2022)
2.3.2 Global Medical Radioactive Source Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Medical Radioactive Source Sales in Volume & Value Estimates and Forecasts
3.1 Global Medical Radioactive Source Sales Estimates and Forecasts 2017-2028
3.2 Global Medical Radioactive Source Revenue Estimates and Forecasts 2017-2028
3.3 Global Medical Radioactive Source Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Medical Radioactive Source Sales by Region
3.4.1 Global Medical Radioactive Source Sales by Region (2017-2022)
3.4.2 Global Sales Medical Radioactive Source by Region (2023-2028)
3.5 Global Medical Radioactive Source Revenue by Region
3.5.1 Global Medical Radioactive Source Revenue by Region (2017-2022)
3.5.2 Global Medical Radioactive Source Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Medical Radioactive Source Production Capacity by Manufacturers
4.2 Global Medical Radioactive Source Sales by Manufacturers
4.2.1 Global Medical Radioactive Source Sales by Manufacturers (2017-2022)
4.2.2 Global Medical Radioactive Source Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Medical Radioactive Source in 2021
4.3 Global Medical Radioactive Source Revenue by Manufacturers
4.3.1 Global Medical Radioactive Source Revenue by Manufacturers (2017-2022)
4.3.2 Global Medical Radioactive Source Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Medical Radioactive Source Revenue in 2021
4.4 Global Medical Radioactive Source Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Medical Radioactive Source Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Medical Radioactive Source Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Medical Radioactive Source Sales by Type
5.1.1 Global Medical Radioactive Source Historical Sales by Type (2017-2022)
5.1.2 Global Medical Radioactive Source Forecasted Sales by Type (2023-2028)
5.1.3 Global Medical Radioactive Source Sales Market Share by Type (2017-2028)
5.2 Global Medical Radioactive Source Revenue by Type
5.2.1 Global Medical Radioactive Source Historical Revenue by Type (2017-2022)
5.2.2 Global Medical Radioactive Source Forecasted Revenue by Type (2023-2028)
5.2.3 Global Medical Radioactive Source Revenue Market Share by Type (2017-2028)
5.3 Global Medical Radioactive Source Price by Type
5.3.1 Global Medical Radioactive Source Price by Type (2017-2022)
5.3.2 Global Medical Radioactive Source Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Medical Radioactive Source Sales by Application
6.1.1 Global Medical Radioactive Source Historical Sales by Application (2017-2022)
6.1.2 Global Medical Radioactive Source Forecasted Sales by Application (2023-2028)
6.1.3 Global Medical Radioactive Source Sales Market Share by Application (2017-2028)
6.2 Global Medical Radioactive Source Revenue by Application
6.2.1 Global Medical Radioactive Source Historical Revenue by Application (2017-2022)
6.2.2 Global Medical Radioactive Source Forecasted Revenue by Application (2023-2028)
6.2.3 Global Medical Radioactive Source Revenue Market Share by Application (2017-2028)
6.3 Global Medical Radioactive Source Price by Application
6.3.1 Global Medical Radioactive Source Price by Application (2017-2022)
6.3.2 Global Medical Radioactive Source Price Forecast by Application (2023-2028)
7 North America
7.1 North America Medical Radioactive Source Market Size by Type
7.1.1 North America Medical Radioactive Source Sales by Type (2017-2028)
7.1.2 North America Medical Radioactive Source Revenue by Type (2017-2028)
7.2 North America Medical Radioactive Source Market Size by Application
7.2.1 North America Medical Radioactive Source Sales by Application (2017-2028)
7.2.2 North America Medical Radioactive Source Revenue by Application (2017-2028)
7.3 North America Medical Radioactive Source Sales by Country
7.3.1 North America Medical Radioactive Source Sales by Country (2017-2028)
7.3.2 North America Medical Radioactive Source Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Medical Radioactive Source Market Size by Type
8.1.1 Europe Medical Radioactive Source Sales by Type (2017-2028)
8.1.2 Europe Medical Radioactive Source Revenue by Type (2017-2028)
8.2 Europe Medical Radioactive Source Market Size by Application
8.2.1 Europe Medical Radioactive Source Sales by Application (2017-2028)
8.2.2 Europe Medical Radioactive Source Revenue by Application (2017-2028)
8.3 Europe Medical Radioactive Source Sales by Country
8.3.1 Europe Medical Radioactive Source Sales by Country (2017-2028)
8.3.2 Europe Medical Radioactive Source Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Medical Radioactive Source Market Size by Type
9.1.1 Asia Pacific Medical Radioactive Source Sales by Type (2017-2028)
9.1.2 Asia Pacific Medical Radioactive Source Revenue by Type (2017-2028)
9.2 Asia Pacific Medical Radioactive Source Market Size by Application
9.2.1 Asia Pacific Medical Radioactive Source Sales by Application (2017-2028)
9.2.2 Asia Pacific Medical Radioactive Source Revenue by Application (2017-2028)
9.3 Asia Pacific Medical Radioactive Source Sales by Region
9.3.1 Asia Pacific Medical Radioactive Source Sales by Region (2017-2028)
9.3.2 Asia Pacific Medical Radioactive Source Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Medical Radioactive Source Market Size by Type
10.1.1 Latin America Medical Radioactive Source Sales by Type (2017-2028)
10.1.2 Latin America Medical Radioactive Source Revenue by Type (2017-2028)
10.2 Latin America Medical Radioactive Source Market Size by Application
10.2.1 Latin America Medical Radioactive Source Sales by Application (2017-2028)
10.2.2 Latin America Medical Radioactive Source Revenue by Application (2017-2028)
10.3 Latin America Medical Radioactive Source Sales by Country
10.3.1 Latin America Medical Radioactive Source Sales by Country (2017-2028)
10.3.2 Latin America Medical Radioactive Source Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Medical Radioactive Source Market Size by Type
11.1.1 Middle East and Africa Medical Radioactive Source Sales by Type (2017-2028)
11.1.2 Middle East and Africa Medical Radioactive Source Revenue by Type (2017-2028)
11.2 Middle East and Africa Medical Radioactive Source Market Size by Application
11.2.1 Middle East and Africa Medical Radioactive Source Sales by Application (2017-2028)
11.2.2 Middle East and Africa Medical Radioactive Source Revenue by Application (2017-2028)
11.3 Middle East and Africa Medical Radioactive Source Sales by Country
11.3.1 Middle East and Africa Medical Radioactive Source Sales by Country (2017-2028)
11.3.2 Middle East and Africa Medical Radioactive Source Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 NRG
12.1.1 NRG Corporation Information
12.1.2 NRG Overview
12.1.3 NRG Medical Radioactive Source Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 NRG Medical Radioactive Source Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 NRG Recent Developments
12.2 Mayak
12.2.1 Mayak Corporation Information
12.2.2 Mayak Overview
12.2.3 Mayak Medical Radioactive Source Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Mayak Medical Radioactive Source Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Mayak Recent Developments
12.3 NTP Radioisotopes
12.3.1 NTP Radioisotopes Corporation Information
12.3.2 NTP Radioisotopes Overview
12.3.3 NTP Radioisotopes Medical Radioactive Source Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 NTP Radioisotopes Medical Radioactive Source Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 NTP Radioisotopes Recent Developments
12.4 ANSTO
12.4.1 ANSTO Corporation Information
12.4.2 ANSTO Overview
12.4.3 ANSTO Medical Radioactive Source Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 ANSTO Medical Radioactive Source Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 ANSTO Recent Developments
12.5 Nordion
12.5.1 Nordion Corporation Information
12.5.2 Nordion Overview
12.5.3 Nordion Medical Radioactive Source Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Nordion Medical Radioactive Source Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Nordion Recent Developments
12.6 IRE
12.6.1 IRE Corporation Information
12.6.2 IRE Overview
12.6.3 IRE Medical Radioactive Source Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 IRE Medical Radioactive Source Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 IRE Recent Developments
12.7 Curium Pharma
12.7.1 Curium Pharma Corporation Information
12.7.2 Curium Pharma Overview
12.7.3 Curium Pharma Medical Radioactive Source Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Curium Pharma Medical Radioactive Source Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Curium Pharma Recent Developments
12.8 Eckert & Ziegler Strahlen
12.8.1 Eckert & Ziegler Strahlen Corporation Information
12.8.2 Eckert & Ziegler Strahlen Overview
12.8.3 Eckert & Ziegler Strahlen Medical Radioactive Source Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Eckert & Ziegler Strahlen Medical Radioactive Source Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Eckert & Ziegler Strahlen Recent Developments
12.9 China Isotope & Radiation Corporation (CIRC)
12.9.1 China Isotope & Radiation Corporation (CIRC) Corporation Information
12.9.2 China Isotope & Radiation Corporation (CIRC) Overview
12.9.3 China Isotope & Radiation Corporation (CIRC) Medical Radioactive Source Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 China Isotope & Radiation Corporation (CIRC) Medical Radioactive Source Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 China Isotope & Radiation Corporation (CIRC) Recent Developments
12.10 Polatom
12.10.1 Polatom Corporation Information
12.10.2 Polatom Overview
12.10.3 Polatom Medical Radioactive Source Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Polatom Medical Radioactive Source Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Polatom Recent Developments
12.11 Board of Radiation and Isotope Technology
12.11.1 Board of Radiation and Isotope Technology Corporation Information
12.11.2 Board of Radiation and Isotope Technology Overview
12.11.3 Board of Radiation and Isotope Technology Medical Radioactive Source Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Board of Radiation and Isotope Technology Medical Radioactive Source Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Board of Radiation and Isotope Technology Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Medical Radioactive Source Industry Chain Analysis
13.2 Medical Radioactive Source Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Medical Radioactive Source Production Mode & Process
13.4 Medical Radioactive Source Sales and Marketing
13.4.1 Medical Radioactive Source Sales Channels
13.4.2 Medical Radioactive Source Distributors
13.5 Medical Radioactive Source Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Medical Radioactive Source Industry Trends
14.2 Medical Radioactive Source Market Drivers
14.3 Medical Radioactive Source Market Challenges
14.4 Medical Radioactive Source Market Restraints
15 Key Finding in The Global Medical Radioactive Source Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の医療用放射線源市場インサイト及び予測（Tc-99m、コバルト60、ヨウ素放射性同位元素）(Global Medical Radioactive Source Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の医療用放射線源市場インサイト及び予測（Tc-99m、コバルト60、ヨウ素放射性同位元素）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp